nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis
|
Lu, Pei-Hua |
|
2010 |
126 |
1 |
p. 249-252 |
artikel |
2 |
Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies
|
Lu, Pei-Hua |
|
2010 |
126 |
1 |
p. 141-148 |
artikel |
3 |
Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects
|
Chen, Min-Bin |
|
2010 |
126 |
1 |
p. 177-183 |
artikel |
4 |
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk
|
Yu, Ke-Da |
|
2010 |
126 |
1 |
p. 37-45 |
artikel |
5 |
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics
|
Kheirelseid, Elrasheid A. H. |
|
2010 |
126 |
1 |
p. 131-140 |
artikel |
6 |
Body weight and risk of breast cancer in BRCA1/2 mutation carriers
|
Manders, Peggy |
|
2010 |
126 |
1 |
p. 193-202 |
artikel |
7 |
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
|
Phillips, Kelly-Anne |
|
2010 |
126 |
1 |
p. 221-226 |
artikel |
8 |
Comments on: Iwasaki et al. Fragment c gamma receptor gene polymorphisms and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
|
Pandey, Janardan P. |
|
2010 |
126 |
1 |
p. 247-248 |
artikel |
9 |
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)
|
Noske, A. |
|
2010 |
126 |
1 |
p. 109-117 |
artikel |
10 |
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
|
Konecny, Michal |
|
2011 |
126 |
1 |
p. 119-130 |
artikel |
11 |
CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis
|
Albasri, Abdulkader |
|
2010 |
126 |
1 |
p. 47-54 |
artikel |
12 |
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study
|
Dawood, Shaheenah |
|
2010 |
126 |
1 |
p. 185-192 |
artikel |
13 |
Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast
|
Lopez-Bonet, Eugeni |
|
2010 |
126 |
1 |
p. 241-245 |
artikel |
14 |
Does radiotherapy planning without breath control compensate intra-fraction heart and its compartments’ movement?
|
Tezcanli, Evrim Kadriye |
|
2010 |
126 |
1 |
p. 85-92 |
artikel |
15 |
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
|
Bardia, Aditya |
|
2010 |
126 |
1 |
p. 149-155 |
artikel |
16 |
Effects of breast cancer surgery and surgical side effects on body image over time
|
Collins, Karen Kadela |
|
2010 |
126 |
1 |
p. 263-264 |
artikel |
17 |
Effects of breast cancer surgery and surgical side effects on body image over time
|
Collins, Karen Kadela |
|
2010 |
126 |
1 |
p. 167-176 |
artikel |
18 |
Effects of breast cancer surgery and surgical side effects on body image over time
|
Munhoz, Alexandre Mendonça |
|
2010 |
126 |
1 |
p. 261-262 |
artikel |
19 |
Erratum to: A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
|
Sugarman, Steven |
|
2009 |
126 |
1 |
p. 267 |
artikel |
20 |
Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
|
Bane, Anita L. |
|
2009 |
126 |
1 |
p. 269 |
artikel |
21 |
Erratum to: The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
|
Tager, Felice A. |
|
2010 |
126 |
1 |
p. 271-272 |
artikel |
22 |
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
|
Goodwin, Pamela J. |
|
2010 |
126 |
1 |
p. 215-220 |
artikel |
23 |
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study
|
Brasky, Theodore M. |
|
2010 |
126 |
1 |
p. 157-165 |
artikel |
24 |
Germline mutations in PALB2 in African-American breast cancer cases
|
Ding, Yuan Chun |
|
2010 |
126 |
1 |
p. 227-230 |
artikel |
25 |
Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration
|
Koro, Konstantin |
|
2010 |
126 |
1 |
p. 73-83 |
artikel |
26 |
Invasive ductal breast cancer associated polymyositis causing respiratory failure
|
Li, Xi |
|
|
126 |
1 |
p. 211-214 |
artikel |
27 |
Invasive ductal breast cancer associated polymyositis causing respiratory failure
|
Li, Xi |
|
2010 |
126 |
1 |
p. 211-214 |
artikel |
28 |
New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk
|
Lu, Pei-Hua |
|
2010 |
126 |
1 |
p. 265-266 |
artikel |
29 |
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population
|
Zhang, Chun |
|
2010 |
126 |
1 |
p. 257-259 |
artikel |
30 |
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women
|
Beesley, Jonathan |
|
2010 |
126 |
1 |
p. 235-239 |
artikel |
31 |
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer
|
Kim, Eun-Kyu |
|
2010 |
126 |
1 |
p. 93-99 |
artikel |
32 |
Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: appraisal of a recent meta-analysis
|
Zhou, Ping |
|
2010 |
126 |
1 |
p. 253-256 |
artikel |
33 |
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients
|
Nagai, Maria Aparecida |
|
2010 |
126 |
1 |
p. 1-14 |
artikel |
34 |
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer
|
Robert, Nicholas J. |
|
2010 |
126 |
1 |
p. 101-108 |
artikel |
35 |
RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
|
Ahmad, Aamir |
|
2010 |
126 |
1 |
p. 15-25 |
artikel |
36 |
Reversed urban–rural differences in breast cancer mortality (China, 2002–2008)
|
He, Min |
|
2010 |
126 |
1 |
p. 231-234 |
artikel |
37 |
Role of ferritin alterations in human breast cancer cells
|
Shpyleva, Svitlana I. |
|
2010 |
126 |
1 |
p. 63-71 |
artikel |
38 |
The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells
|
Lu, Yan |
|
2010 |
126 |
1 |
p. 27-36 |
artikel |
39 |
The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs
|
Atipairin, Apichart |
|
2010 |
126 |
1 |
p. 203-209 |
artikel |
40 |
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines
|
Millon, Stacy R. |
|
2010 |
126 |
1 |
p. 55-62 |
artikel |